Literature DB >> 26918421

Mental slowing in relation to epilepsy and antiepileptic medication.

E Grevers1, L E M Breuer1,2, D M IJff1,3, A P Aldenkamp1,2,3,4,5.   

Abstract

OBJECTIVES: Slowing of the central information-processing speed (CIPS) is frequently observed in epilepsy as a consequence of epileptic seizures and/or antiepileptic drugs (AEDs). A variety of neuropsychological tests are used to asses this 'mental slowing,' but it is highly questionable whether the different tasks measure the same cognitive process. Also, it remains unspecified to which degree the various tasks are sensitive to seizure- or treatment-related factors, or both.
METHODS: We used an open clinical non-comparative study design. The sample consisted of adult patients with cryptogenic localization-related epilepsy who performed different cognitive measures of CIPS and psychomotor speed (PmS). Clinical data about their seizures and antiepileptic drug treatment were collected from an electronic patient database.
RESULTS: Eighty patients were included. CIPS tasks mutually correlated significantly, but did not correlate with measures of PmS (finger tapping and reaction time). Also, the CIPS tasks were differently affected by treatment and seizure effects. Processing of complex information is affected by tonic-clonic seizures, while less complex tasks are more sensitive for AED effects.
CONCLUSIONS: CIPS tasks are mainly measuring central processing, and the psychomotor component of these tasks is negligible. We propose a psychometric continuum on which PmS and CIPS tasks are ordered with ascending complexity. The model shows that the tasks are affected differently by seizures, treatment, age, and education level. In neuropsychological practice, this continuum can be helpful in the detection of treatment and seizure effects on the CIPS in epilepsy.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  antiepileptic drugs; central information-processing speed; cognitive measures; epileptic seizures; psychomotor speed

Mesh:

Substances:

Year:  2015        PMID: 26918421     DOI: 10.1111/ane.12517

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  6 in total

1.  Cognitive slowing and its underlying neurobiology in temporal lobe epilepsy.

Authors:  Gyujoon Hwang; Kevin Dabbs; Lisa Conant; Veena A Nair; Jed Mathis; Dace N Almane; Andrew Nencka; Rasmus Birn; Colin Humphries; Manoj Raghavan; Edgar A DeYoe; Aaron F Struck; Rama Maganti; Jeffrey R Binder; Elizabeth Meyerand; Vivek Prabhakaran; Bruce Hermann
Journal:  Cortex       Date:  2019-03-05       Impact factor: 4.027

2.  The Cognitive Profile of Ethosuximide in Children.

Authors:  Dominique M IJff; Tamar M van Veenendaal; Mariette H Debeij-van Hall; Jacobus F A Jansen; Anton J A de Louw; Marian H J M Majoie; Albert P Aldenkamp
Journal:  Paediatr Drugs       Date:  2016-10       Impact factor: 3.022

3.  Chronic antiepileptic drug use and functional network efficiency: A functional magnetic resonance imaging study.

Authors:  Tamar M van Veenendaal; Dominique M IJff; Albert P Aldenkamp; Richard H C Lazeron; Paul A M Hofman; Anton J A de Louw; Walter H Backes; Jacobus F A Jansen
Journal:  World J Radiol       Date:  2017-06-28

4.  Reference ranges for antiepileptic drugs revisited: a practical approach to establish national guidelines.

Authors:  Arne Reimers; Jon Andsnes Berg; Margrete Larsen Burns; Eylert Brodtkorb; Svein I Johannessen; Cecilie Johannessen Landmark
Journal:  Drug Des Devel Ther       Date:  2018-02-08       Impact factor: 4.162

5.  The impact of processing speed on cognition in temporal lobe epilepsy.

Authors:  Taylor M McMillan; Craig A Mason; Michael Seidenberg; Jana Jones; Bruce Hermann
Journal:  Epilepsy Behav       Date:  2021-07-15       Impact factor: 3.337

6.  Psychomotor slowing is associated with anomalies in baseline and prospective large scale neural networks in youth with epilepsy.

Authors:  Camille Garcia-Ramos; Kevin Dabbs; Elizabeth Meyerand; Vivek Prabhakaran; David Hsu; Jana Jones; Michael Seidenberg; Bruce Hermann
Journal:  Neuroimage Clin       Date:  2018-04-20       Impact factor: 4.881

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.